Fujian South Pharmaceutical Co. Ltd · 66-66 · CHINA
For Fujian South Pharmaceutical Co. Ltd, import alert is 66-66; country is CHINA; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Paclitaxel; product code is 62 I - - 91 Paclitaxel (Anti-Neoplastic); date published is 08/14/2012; address is Mingxi County , No. 98 Dongxin Road; Xuefengzhen Mingxixian , Sanming, Fujian CHINA, verified against its source on 2026-09-30.
- Firm
- Fujian South Pharmaceutical Co. Ltd verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- CHINA verified
- Address
- Mingxi County , No. 98 Dongxin Road; Xuefengzhen Mingxixian , Sanming, Fujian CHINA verified
- Date published
- 08/14/2012 verified
- Product code
- 62 I - - 91 Paclitaxel (Anti-Neoplastic) verified
- Product
- Paclitaxel verified
What the source says
Fujian South Pharmaceutical Co. Ltd Date Published : 08/14/2012 Mingxi County , No. 98 Dongxin Road; Xuefengzhen Mingxixian , Sanming, Fujian CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code and Product
62 I - - 91 Paclitaxel (Anti-Neoplastic) Date Published: 08/14/2012 Desc: Paclitaxel
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.